Donecopride, a Swiss army knife with potential against Alzheimer's disease.
Christophe RochaisCédric LecouteyKatia HamidouchePatrizia GiannoniFlorence GavenEleazere CemSerge MignaniKevin BarangerThomas FreretJoël BockaertSantiago RiveraMichel BoulouardPatrick DallemagneSylvie ClaeysenPublished in: British journal of pharmacology (2020)
Donecopride acts like a Swiss army knife, exhibiting a range of sustainable symptomatic therapeutic effects and potential disease-modifying effects in models of AD. Clinical trials with this promising drug candidate will soon be undertaken to confirm its therapeutic potential in humans.